Meta description: A trial evaluating an augmented reality discharge information app completed at Hospital Universitario Getafe and targets cardiology patients with myocardial infarction, prior pacemaker implantation, heart failure and atrial fibrillation.
The sponsor is Hospital Universitario Getafe and the registry marks the study as completed. The report outlines a device described as an augmented reality application used to convey discharge information within the hospital setting. No efficacy results are provided in the source text. Stakeholders in clinical care and device regulation should monitor for published outcomes.
What changed in discharge information testing for cardiology patients?
The registry notes conditions including myocardial infarction, prior pacemaker implantation, heart failure and atrial fibrillation as part of the study scope. The intervention is listed as a device described as an augmented reality app. The aim is to deliver discharge information to hospitalized patients using AR technology. The information in the source text does not report results, but it indicates the approach is being evaluated in a hospital setting. The use of AR in discharge education is presented as a novel approach with potential to standardize information across patient groups and care teams, but readers should await actual results before drawing conclusions about usability or impact.
In regulatory terms the entry serves as a registry record for a device based intervention intended to support patient education at discharge. Details about training requirements, interoperability with existing hospital systems, or data safety considerations are not provided in the text, making further assessment dependent on forthcoming publications.
What is the device and who sponsors the study?
The device entry in the source is an augmented reality app. It is described as a tool to provide discharge information to patients. The sponsor listed is Hospital Universitario Getafe, a Spanish hospital. The study status is completed, with no results in the provided text. The AR app is categorized as a device level intervention rather than a consumer facing product, which has implications for regulatory oversight and future reporting requirements. The absence of published results means that no major conclusions about patient outcomes or safety can be drawn from the registry alone.
What is the status and what are the potential implications for care?
The registry identifies the study as completed. The text does not include published outcomes or effectiveness claims. If future results show benefits in patient understanding or discharge processes, AR based discharge information could influence education and hospital workflow for cardiology patients. Clinicians should await peer reviewed publications for robust conclusions. From a clinical practice perspective such tools could address variability in how discharge information is delivered and may support patients with complex medical histories. However, it is important to see data on usability, training needs and integration with discharge checklists before widespread adoption.
What does this mean from a regulatory perspective?
From a regulatory viewpoint the entry describes an intended use and device type without performance data. MDR style interpretation would emphasize the intended purpose and safety considerations rather than efficacy or conformity statements. The text does not imply regulatory clearance or marketing authorization. In practice a device level AR application would require appropriate documentation for any future submissions to regulators, including risk analysis, evidence of safety and performance, and a plan for post market surveillance if results become available.
Conclusion
The completed trial signals interest in AR based discharge education for complex cardiology care. Readers should monitor for results in the public domain to assess safety, usability and impact on patient education. As with any novel information tool in hospital care, stakeholders should consider training, patient access, language support and data privacy implications when results become available.
FAQ
- What conditions are included in the study? The registry lists myocardial infarction, prior pacemaker implantation, heart failure and atrial fibrillation as conditions in scope.
- What is the device used in the study? It is described as an augmented reality app intended to convey discharge information to hospitalized patients.
- Where can I find more information about the trial? The ClinicalTrials.gov entry is NCT07399379 and the provided link is https://clinicaltrials.gov/study/NCT07399379?term=medical+device.
Disclaimer
This article is intended for professionals and does not constitute legal advice. It summarizes the source text and does not claim clinical outcomes.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07399379?term=medical+device